{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:30:41Z","timestamp":1792153841004,"version":"4.4.0"},"reference-count":51,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A20842"],"award-info":[{"award-number":["A20842"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["TLD-PF21-001"],"award-info":[{"award-number":["TLD-PF21-001"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Queen\u2019s Foundation, Queen\u2019s University Belfast","award":["A20842"],"award-info":[{"award-number":["A20842"]}]},{"name":"Queen\u2019s Foundation, Queen\u2019s University Belfast","award":["TLD-PF21-001"],"award-info":[{"award-number":["TLD-PF21-001"]}]},{"name":"LFT Charitable Trust","award":["A20842"],"award-info":[{"award-number":["A20842"]}]},{"name":"LFT Charitable Trust","award":["TLD-PF21-001"],"award-info":[{"award-number":["TLD-PF21-001"]}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK Career Acceleration Fellowship","doi-asserted-by":"publisher","award":["A20842"],"award-info":[{"award-number":["A20842"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK Career Acceleration Fellowship","doi-asserted-by":"publisher","award":["TLD-PF21-001"],"award-info":[{"award-number":["TLD-PF21-001"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Radiotherapy (RT) treatment is an important strategy for the management of non-small cell lung cancer (NSCLC). Local recurrence amongst patients with late-stage NSCLC remains a challenge. The loss of PTEN has been associated with radio-resistance. This study aimed to examine the efficacy of RT combined with ataxia telangiectasia-mutated Rad3-related (ATR) inhibition using Ceralasertib in phosphatase and tensin homolog (PTEN)-depleted NSCLC cells and to assess early inflammatory responses indicative of radiation pneumonitis (RP) after combined-modality treatment. Small hairpin RNA (shRNA) transfections were used to generate H460 and A549 PTEN-depleted models. Ceralasertib was evaluated as a single agent and in combination with RT in vitro and in vivo. Histological staining was used to assess immune cell infiltration in pneumonitis-prone C3H\/NeJ mice. Here, we report that the inhibition of ATR in combination with RT caused a significant reduction in PTEN-depleted NSCLC cells, with delayed DNA repair and reduced cell viability, as shown by an increase in cells in Sub G1. Combination treatment in vivo significantly inhibited H460 PTEN-depleted tumour growth in comparison to H460 non-targeting PTEN-expressing (NT) cell-line-derived xenografts (CDXs). Additionally, there was no significant increase in infiltrating macrophages or neutrophils except at 4 weeks, whereby combination treatment significantly increased macrophage levels relative to RT alone. Overall, our study demonstrates that ceralasertib and RT combined preferentially sensitises PTEN-depleted NSCLC models in vitro and in vivo, with no impact on early inflammatory response indicative of RP. These findings provide a rationale for evaluating ATR inhibition in combination with RT in NSCLC patients with PTEN mutations.<\/jats:p>","DOI":"10.3390\/ijms25147817","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T16:35:58Z","timestamp":1721234158000},"page":"7817","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC)"],"prefix":"10.3390","volume":"25","author":[{"given":"Victoria L.","family":"Dunne","sequence":"first","affiliation":[{"name":"Patrick G Johnston Centre for Cancer Research, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2467-9156","authenticated-orcid":false,"given":"Mihaela","family":"Ghita-Pettigrew","sequence":"additional","affiliation":[{"name":"Patrick G Johnston Centre for Cancer Research, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Redmond","sequence":"additional","affiliation":[{"name":"Patrick G Johnston Centre for Cancer Research, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Small","sequence":"additional","affiliation":[{"name":"Patrick G Johnston Centre for Cancer Research, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5628-6624","authenticated-orcid":false,"given":"Sin\u00e9ad","family":"Weldon","sequence":"additional","affiliation":[{"name":"Airway Innate Immunity Research Group (AiiR), Wellcome Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C.","family":"Taggart","sequence":"additional","affiliation":[{"name":"Airway Innate Immunity Research Group (AiiR), Wellcome Wolfson Institute for Experimental Medicine, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6134-7946","authenticated-orcid":false,"given":"Kevin M.","family":"Prise","sequence":"additional","affiliation":[{"name":"Patrick G Johnston Centre for Cancer Research, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-5138","authenticated-orcid":false,"given":"Gerard G.","family":"Hanna","sequence":"additional","affiliation":[{"name":"Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-6789","authenticated-orcid":false,"given":"Karl T.","family":"Butterworth","sequence":"additional","affiliation":[{"name":"Patrick G Johnston Centre for Cancer Research, Queen\u2019s University Belfast, Belfast BT9 7AE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1378\/chest.128.6.3975","article-title":"Targeted Therapy for the Treatment of Advanced Non-small Cell Lung Cancer","volume":"128","author":"Silvestri","year":"2005","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"37589","DOI":"10.18632\/oncotarget.26428","article-title":"Targeted therapies for advanced non-small cell lung cancer","volume":"9","author":"Ai","year":"2018","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","first-page":"152","article-title":"Adaptive resistance to targeted therapies in cancer","volume":"2","author":"Rosell","year":"2013","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.apsb.2018.04.005","article-title":"Personalized medicine in non-small cell lung cancer: A review from a pharmacogenomics perspective","volume":"8","author":"Jiang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.lungcan.2009.11.012","article-title":"PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers","volume":"69","author":"Jin","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1002\/cncr.30794","article-title":"Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy","volume":"123","author":"Cassidy","year":"2017","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5858\/arpa.2017-0046-OA","article-title":"Next-Generation Sequencing Approach to Non\u2013Small Cell Lung Carcinoma Yields More Actionable Alterations","volume":"142","author":"Mehrad","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gkountakos, A., Sartori, G., Falcone, I., Piro, G., Ciuffreda, L., Carbone, C., Tortora, G., Scarpa, A., Bria, E., and Milella, M. (2019). PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around. Cancers, 11.","DOI":"10.3390\/cancers11081141"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/JTO.0b013e3182641d4f","article-title":"Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma","volume":"7","author":"Yanagawa","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"57832","DOI":"10.18632\/oncotarget.11068","article-title":"PTEN expression is a prognostic marker for patients with non-small cell lung cancer: A systematic review and meta-analysis of the literature","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40880-019-0354-z","article-title":"Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations","volume":"39","author":"Wang","year":"2019","journal-title":"Cancer Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2012.01.003","article-title":"PTEN in DNA damage repair","volume":"319","author":"Ming","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1236188","article-title":"Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress","volume":"341","author":"Bassi","year":"2013","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejca.2013.11.027","article-title":"New radiotherapy approaches in locally advanced non-small cell lung cancer","volume":"50","author":"Christodoulou","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mar\u00e9chal, A., and Zou, L. (2013). DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol., 5.","DOI":"10.1101\/cshperspect.a012716"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: Ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug\u2013radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09553002.2020.1707325","article-title":"A potential new role of ATM inhibitor in radiotherapy: Suppressing ionizing Radiation-Activated EGFR","volume":"96","author":"Tang","year":"2020","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.radonc.2017.06.025","article-title":"Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy","volume":"124","author":"Dunne","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Takeuchi, M., Tanikawa, M., Nagasaka, K., Oda, K., Kawata, Y., Oki, S., Agapiti, C., Sone, K., Miyagawa, Y., and Hiraike, K. (2019). Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells. Cancers, 11.","DOI":"10.3390\/cancers11121913"},{"key":"ref_28","first-page":"61","article-title":"CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer","volume":"25","author":"Walls","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.2008.16.0812","article-title":"A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair","volume":"26","author":"Ashworth","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-018-4683-4","article-title":"Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy","volume":"169","author":"Ali","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yexcr.2018.03.006","article-title":"ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin","volume":"366","author":"Li","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1158\/0008-5472.CAN-14-3502","article-title":"Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM","volume":"1","author":"McCabe","year":"2015","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1437","DOI":"10.1038\/cddis.2014.415","article-title":"PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways","volume":"5","author":"Chang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hanna, C., Dunne, V.L., Walker, S.M., Butterworth, K.T., McCabe, N., Waugh, D.J.J., Kennedy, R., and Prise, K.M. (2020). ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation. Cancers, 13.","DOI":"10.3390\/cancers13010079"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1038\/s41598-018-22289-7","article-title":"Loss of PTEN-assisted G2\/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer","volume":"8","author":"Mansour","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.4161\/cc.10.13.16305","article-title":"MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks","volume":"10","author":"Fraser","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"21206","DOI":"10.1074\/jbc.M703042200","article-title":"Inhibition of Phosphatidylinositol-3-OH Kinase\/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation","volume":"282","author":"Kao","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.cgt.7701050","article-title":"Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity","volume":"14","author":"Pappas","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"110106","DOI":"10.1016\/j.radonc.2024.110106","article-title":"Characterisation of quantitative imaging biomarkers for inflammatory and fibrotic radiation-induced lung injuries using preclinical radiomics","volume":"192","author":"Brown","year":"2024","journal-title":"Radiother. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1269\/jrr.11054","article-title":"The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice","volume":"52","author":"Zhang","year":"2011","journal-title":"J. Radiat. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ijrobp.2016.06.167","article-title":"The Expression of CXCL16 During Lung Irradiation May Lead to Radiation Pneumonitis and Fibrosis Through Inducing Neutrophil and Macrophage Infiltration in Lung Tissue","volume":"96","author":"Chen","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/JTO.0000000000000677","article-title":"Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils","volume":"10","author":"Abernathy","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI58928","article-title":"Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR","volume":"122","author":"Schoppy","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clon.2020.02.003","article-title":"The UK at the Forefront of Innovative Drug\u2013Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform","volume":"32","author":"Brown","year":"2020","journal-title":"Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.eururo.2012.08.032","article-title":"Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma","volume":"64","author":"Maxwell","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.103.5.653","article-title":"Action of x-rays on mammalian cells","volume":"103","author":"Puck","year":"1956","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Guerra Liberal, F.D.C., Moreira, H., Redmond, K.M., O\u2019Sullivan, J.M., Alshehri, A.H.D., Wright, T.C., Dunne, V.L., Campfield, C., Biggart, S., and McMahon, S.J. (2022). Differential responses to 223Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.877302"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7817\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:18:19Z","timestamp":1760109499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":51,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25147817"],"URL":"https:\/\/doi.org\/10.3390\/ijms25147817","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}